719 — Shandong Xinhua Pharmaceutical Co Balance Sheet
0.000.00%
Last trade - 00:00
- HK$3.72bn
- HK$5.14bn
- CNY8.10bn
- 73
- 93
- 16
- 68
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | CAS | CAS | CAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 578 | 723 | 596 | 1,011 | 782 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 534 | 607 | 920 | 1,032 | 1,017 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,428 | 2,687 | 2,754 | 3,457 | 3,314 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3,201 | 3,539 | 3,766 | 4,000 | 4,061 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 6,436 | 7,093 | 7,332 | 8,265 | 8,286 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,486 | 2,381 | 2,502 | 3,158 | 2,486 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 3,467 | 3,869 | 3,864 | 4,139 | 3,733 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,969 | 3,224 | 3,468 | 4,126 | 4,553 |
Total Liabilities & Shareholders' Equity | 6,436 | 7,093 | 7,332 | 8,265 | 8,286 |
Total Common Shares Outstanding |